Objective: Baseline concentrations of plasma C-reactive protein (CRP) are associated with coronary heart disease. Interleukin-6 (IL-6) regulates CRP gene expression; a promoter polymorphism (-174G / C) of the IL-6 gene has been shown to influence IL-6 transcription but the relationship between genotype at this polymorphism and circulating levels of inflammatory markers remains unclear. We hypothesised that plasma CRP would be a heritable phenotype that would be influenced by genotype at this polymorphism. Methods: We measured baseline plasma CRP and determined genotypes at the -174G / C polymorphism of the IL-6 gene in 588 members of 98 nuclear families. The heritability of plasma CRP and the association of plasma CRP with genotype were determined using variance components methods. Results: Baseline CRP levels were highly heritable (h 50.39, P,0.0000001). Presence of the -174C allele was associated with higher baseline CRP levels, both in the whole population (P50.01), and in the founders only (n5128, P50.001). Family-based analyses confirmed the association (P50.02) suggesting that it arises from chromosomal proximity or identity of the typed polymorphism with a genetic variant influencing baseline CRP levels. Conclusions: Baseline plasma CRP is a significantly heritable cardiovascular risk factor. Levels are associated with genotype at the -174G / C polymorphism of the IL-6 gene.
Introduction
data from intervention trials also suggests that baseline CRP may be a useful marker to identify subjects without To date, 11 prospective studies involving a total of overt hyperlipidaemia or previous coronary events who nearly 2000 cases of disease have demonstrated association may nevertheless derive benefit from statin therapy, which between the baseline level of plasma C-reactive protein is thought to be due to a direct anti-inflammatory effect of (CRP) and coronary heart disease (CHD) [1] . It is statins on atheromatous plaques [3] . There is therefore uncertain whether this association is causal; several mechaconsiderable interest in establishing the degree to which nisms whereby CRP might directly influence atherogenesis baseline CRP is genetically determined, and in identifying have been proposed, but none has been proven [2] . Recent genetic polymorphisms that are associated with CRP levels. Baseline plasma CRP levels (that is, plasma CRP levels measured in the absence of any clinically recognised ty in one study [4] , but no genetic polymorphisms associphenotype influenced by the IL-6 -174G / C polymorated with baseline levels of plasma CRP have yet been phism, and have tested this in a large family study. reported. If genetic variability between individuals could be shown to contribute substantially to the overall population variability of CRP, then CRP could potentially be used 2. Methods as an intermediate phenotype for genetic analysis that might be more tractable than the more complex phenotype 2.1. Family collection of clinical CHD, which would be expected to result from a wider variety of genetic and environmental factors. GeNinety-eight British Caucasian families were ascertained netic variants associated with baseline levels of plasma on a proband with essential hypertension found to be in the CRP would be strong candidates as CHD susceptibility top 5% of the population blood pressure distribution before alleles.
the age of 65 years. Probands were identified from a Interleukin-6 (IL-6) is a major determinant of the acute hospital hypertension service or via their family physiphase response. Expression of the CRP gene during the cians. Families of the probands were collected when a acute-phase reaction is regulated by IL-6, although the sibship of three members available for phenotyping and importance of IL-6 in determining baseline plasma levels blood sampling was available, if a parent of the sibship of CRP is unknown. Genotypes at a recently described was also available for blood sampling. When no parent was polymorphism of the IL-6 promoter (-174G / C), which available, a sibship of four was required. The sibship could influences IL-6 gene transcription in vitro, have been be in the generation of the proband or of his / her offspring, examined for association with plasma IL-6 levels in a and when suitable sibships existed in both generations, number of studies, but the results of these studies have they were both collected. There was no requirement for been widely discrepant [5] [6] [7] [8] [9] . This may be chiefly as a any member of the family other than the proband to be result of random error in relatively modest sample sizes, classified as hypertensive. However, when a member of a but may also be partly due to the marked (sixfold) diurnal sibship so collected could be determined to be hypertenvariability of plasma IL-6, which may limit the intrasive (by the same criteria as the probands), then, if a individual replicability of plasma IL-6 measurements [10-suitable sibship existed in the generation of his / her 12]. Baseline CRP concentrations are not subject to such offspring, that sibship was also collected. circadian variation and show high reproducibility within
Research personnel administered a detailed quesindividuals over a period of up to 5 years [13] [14] [15] . This tionnaire regarding current and previous health, including may explain the apparent superiority of CRP to IL-6 as a the presence of any acute or chronic inflammatory conpredictor of vascular risk that has been observed in some ditions, to all participants. Height, weight and blood prospective studies, and suggests that CRP may be a more pressure (using a Takeda TM2421 automated suitable phenotype than IL-6 for investigation regarding sphygmomanometer) were measured in all subjects. Blood any possible genetically determined level of baseline was drawn for baseline biochemical analysis and urine inflammatory activity that may contribute to the risk of dipstick testing for haematuria and albuminuria was carried atherothrombotic events [16, 17] . The relationship between out. All proband and family data were clinically evaluated the IL-6 -174G / C polymorphism and baseline plasma by one of the investigators (B.K.) to detect the presence of CRP levels has been examined in some of those studies secondary hypertension, including Mendelian forms of that investigated the association between genotype and genetic hypertension; where this could not be confidently plasma IL-6 levels. Although no evidence of an association excluded in a family, the family was excluded from the has been found thus far, in some studies the sensitivity of study. the CRP assay used was limited [9] , whilst in others all
The study conforms with the principles outlined in the individuals enrolled were patients with established atherosDeclaration of Helsinki. clerotic disease which may itself have influenced the measured levels of plasma CRP [6, 8] .
2.2. Genotyping All studies to date that have examined association between the IL-6 -174 G / C polymorphism and plasma
The G / C polymorphism at position -174 of the levels of inflammatory markers have been conducted in interleukin-6 gene was typed by polymerase chain reaction unrelated individuals. Such studies are potentially suscep-(PCR) amplification using primer pairs tible to problems arising from genetic inhomogeneity of 59CACTCCACCTGGAGACGCCT39and 59TCCCTCAC-the study subjects; although the practical magnitude of this ACAGGGCTCGAC39 under standard conditions using 2 concern is uncertain, it can be avoided if families are mM MgCl , followed by restriction digestion with NlaIII 2 studied [18]. Additionally, family studies offer the advanand agarose gel electrophoresis. Control individuals of tages that they permit the heritability of a phenotype to be known genotype were included in each plate, and genotypestimated, and the requirement for Mendelian transmission ing was carried out blinded to plasma CRP levels. Menprovides an in-built check on genotyping accuracy. delian inheritance within families was confirmed using the We hypothesised that plasma CRP would be a heritable PedCheck programme [19] and inconsistencies resolved by Table 1 re-examination of the raw data, and re-genotyping where radish peroxidase. Binding was visualised with urea hydrogen peroxide and 3,39,5,59-tetramethylbenzidine. The reaction was calibrated against international standard 85 / 506 of the subjects studied are shown in Table 1 . CRP levels CRP (NIBSC), threefold serially diluted over a range of corresponded closely with those described in other popula-0.1 to 0.00123 mg / l although the range from which tions without inflammatory disease (median 1.26 mg / l, samples were read was usually 0.033-0.0037 mg / l. Saminterquartile range 0.51-3.07 mg / l). CRP levels were ples were initially tested at three threefold serially diluted skewed, and were therefore transformed for further analyconcentrations and each dilution tested in duplicate. For sis by taking the natural logarithm, which resulted in an the reading to be valid two of the dilutions had to lie approximately Normal distribution (Kolmogorov-Smirwithin the appropriate portion of the standard curve and nov / Lillefors statistic50.027, P50.2; Fig. 1 ). No subject had to be within 10% of one another. If these conditions reported symptoms of current inflammatory disease that were not met, the assay was repeated at more appropriate might have invalidated their baseline CRP measurement. dilutions. The intra-plate relative standard deviation (RSD)
Six subjects had previous histories of inflammatory conwas measured by measuring CRP in an aliquoted normal ditions (inflammatory arthropathy in four cases and inplasma pool on single plates using all available positions. flammatory bowel disease in two cases) that were clinically Each sample plate measured at least three dilutions of inactive at the time of blood collection. With one excepnormal pool and these values were used to correct for tion, all these subjects had CRP levels below the median. differences between plates. The inter-plate RSD was Analyses were conducted both including and excluding calculated by comparing valid values obtained for samples these individuals; the significance of the results was between plates; each plate had an average of 14.3 comunaltered. Age and body mass index (BMI) were highly parisons made with other plates. The intra-and inter-assay significant covariates of log CRP (P,0.001) while ageRSDs were 10.4 and 15.9%, respectively. The lower squared, sex, age-by-sex, and smoking were not (P.0.05 detection limit of the assay was 0.02 mg / l. Samples were for all). Prior to adjustment for age and BMI, there was a assayed without regard to family relationships to avoid trend towards association between systolic blood pressure systematic bias.
and log plasma CRP (P50.05); however, after adjustment for age and BMI, there was no significant association 2.4. Statistical methods either between systolic or diastolic blood pressure as continuous variables and log CRP, or between hypertenThe presence and significance of covariates of log plasma CRP was assessed by stepwise linear regression using SPSS statistical software (SPSS). Log CRP levels were analysed for association with genotype in the entire population and, separately, in the founders of the families only (i.e., those whose parents did not appear in the pedigree) by analysis of variance. Family-based tests of association of log plasma CRP with the typed marker were carried out using a variance components approach implemented in the QTDT program [20] . The heritability of log plasma CRP was determined using SOLAR [21] .
Results
The 98 families comprised 588 members with reliable measurements of baseline plasma CRP and genotype information. Seventy-five percent of families comprised genotyped founders. Among 588 subjects with G / G, G / C and C / C genotypes, the age and BMI adjusted log CRP levels were 0.01 (S.E. 0.10), 0.29 (0.07) and 0.28 (0.16), respectively, suggesting that the C allele was behaving in a dominant fashion to increase log CRP (Fig. 2) . As our initial hypothesis had been that any association would follow a codominant model, this model was tested first. There was significant evidence for association between genotypes and log CRP level in the whole population (F53.348, P50.036; Table 2 ) and in the founders (F5 5.640, P50.005; Table 2 ). However, under a dominant model (GG versus GC and CC), there was stronger evidence of association between genotype and log CRP level in the whole population (F56.523, P50.011; Table  2 ) and in the founders (F511.33, P50.001; Table 2 ). We accounted for multiple hypothesis testing by applying a Bonferroni correction for two analyses; following this, associations observed under the dominant model remained significant. Under the dominant model in the founders, genotype explained 14% of the observed variation in log plasma CRP. Family-based analyses using QTDT gave further support for association between genotype and log CRP (F55.18, P50.0232). There was a tendency towards higher baseline CRP levels in the founders (mean log CRP of 0.72 in founders compared with 0.05 in nonfounders) but after adjustment for age and BMI this difference was non-significant (P50.38), and there was no evidence for ing the influence of genotype on log CRP (P50.4). sion affection status and log CRP (P.0.1 for all). Log CRP values were therefore adjusted for age and BMI by 4. Discussion linear regression prior to genetic analysis. Since no significant relationship had been demonstrated between blood Our study shows that baseline plasma CRP level is a pressure, for which these families had been ascertained, highly heritable phenotype which is associated with genoand log CRP, no ascertainment correction was applied to type at the IL-6 -174G / C polymorphism. The high the data. Log CRP adjusted for age and BMI was highly heritability (0.39) of baseline CRP that we have observed 2 heritable in these families (h 50.39, P,0.0000001). in families ascertained on a hypertensive proband closely The frequency of the commoner G allele at the IL6 agrees with a recent report by Pankow et al. [4] who -174G / C polymorphism was 0.57 (in agreement with studied randomly ascertained families and found a previous reports in Caucasian populations), and genotype heritability of 0.35-0.4 for baseline CRP. This confirms frequencies did not differ significantly from Hardy-Weinthe suitability of our families for such analyses, and berg proportions in the total population or in the 128 indicates that CRP is determined to a significant degree by Table 2 Association of IL-6-(-174) G / C polymorphism with log plasma CRP levels in entire population and founder individuals genetic factors rather than exclusively by random, inThe reasons for the discrepancies among these other dividual-specific responses to concurrent inflammatory studies, and between those studies and the present study, stimuli. In view of the association between CRP and are unclear. However, most of the previous studies have atherothrombotic events, the high heritability of CRP involved substantially smaller samples than the present suggests that CRP may have value as an intermediate study, and the levels of statistical significance of the phenotype in genetic studies of CHD susceptibility. In observed associations have typically been modest, so the addition to our findings regarding the heritability of CRP, discrepancies may be due to random error. The tendency to this study is the first to our knowledge that demonstrates random error may have been exacerbated by the marked association between any genetic polymorphism and the diurnal variability of plasma IL-6, since timed samples baseline plasma level of CRP. The study is also the largest were not taken in most of these studies. Some studies thus far to investigate the relationship between the IL-6 enrolled healthy individuals, whereas other studies enrolled -174 G / C polymorphism and any inflammatory cytokine.
patients with clinically apparent atherosclerotic disease, in Its family-based design allows estimation of the heritability whom the presence of the disease itself may have conof plasma CRP, and acts as a control for population founded any genetic influence on plasma CRP or IL-6 stratification.
levels. All studies have all been performed in European The IL6 -174G / C polymorphism is a credible bioCaucasian populations and the allele frequencies in these logical candidate for involvement in the regulation of the studies have been in good agreement with each other; inflammatory response; it is situated close to a binding site however, only the present study has a family-based design, for the glucocorticoid receptor and the nucleotide substituwhich can eliminate the risk of false-positive results due to tion creates a potential binding site for the transcription undetected subtle population stratification. Our data show factor NF-1 [22] . However, previous population genetic highly significant association between the C allele and studies are inconclusive regarding which of the alleles is baseline plasma CRP levels, and provide the strongest associated with higher plasma levels of inflammatory evidence so far for an effect of this polymorphism on the cytokines. Fishman et al. showed in 92 healthy subjects regulation of baseline plasma cytokine levels. that the mean plasma IL-6 level was lower in those of CC One limitation of our study is that plasma IL-6 levels genotype than in those of GG or GC genotype (P50.02),
were not measured (as it was not possible to obtain blood suggesting a recessive effect of the C allele in lowering samples from all subjects at standardised times), which plasma IL-6 [5] . However, Rauramaa et al. found no effect means that the mechanism of the association remains of the polymorphism on baseline plasma IL-6 levels in 92 uncertain. We hypothesise that the IL-6 -174C allele asymptomatic males [7] . Subsequently Jones et al. preincreases baseline plasma CRP via an influence on IL-6 sented data on 231 patients with abdominal aortic gene transcription and the consequent effects of differing aneurysms and showed a borderline significant (P50.047) levels of that cytokine on CRP gene expression. However, codominant effect of the polymorphism on plasma in the absence of IL-6 levels, alternative explanations, such levels, the presence of the C allele being associated with as linkage disequilibrium between this polymorphism and higher plasma IL-6 levels in a codominant fashion [6] .
others either within the IL-6 gene affecting IL-6 protein That study also investigated the effect of genotype at this function rather than concentration, or within other genes polymorphism on plasma CRP; no significant association neighbouring IL-6 that directly affect CRP gene transcripwas observed. Margaglione et al. found no association tion in other ways, cannot be ruled out. Further studies will between genotype and plasma levels of either CRP or IL-6 therefore be necessary to clarify the mechanism of the in 598 randomly ascertained individuals, but the reproassociation. ducibility of the plasma assays used in that study was low Somewhat surprisingly, we observed an apparent domiat lower levels of CRP and IL-6; this resulted in the use of nant effect of the C allele on baseline plasma CRP levels, the plasma phenotypes as dichotomous rather than continuwhich potentially invokes a threshold effect of IL-6 gene ous variables, which may have diminished the power of transcription on CRP levels. This does not diminish the that study to detect any genetic effect [9] . Most recently, likelihood of our result being correct: there are many Brull et al. found no association between genotype and examples of genetic effects on quantitative traits that are plasma IL-6 levels in a study of 127 patients undergoing not co-dominant (for example, the association between the CABG, although a recessive effect of the C allele to MTHFR C677T mutation and plasma homocysteine levels, increase plasma IL-6 levels 6 h after CABG appeared to be which has been observed in over 5000 cases of carpresent (P50.04) [8] . Those studies that have examined diovascular disease and controls [23] ). We typed a polyclinical vascular phenotypes with respect to these genomorphism in the IL-6 rather than the CRP gene: although types have likewise tended to be discrepant: the C allele some polymorphisms in the CRP gene have been described was associated with a lesser severity of carotid artery [24] , none appear to be such good candidates as regulatory atherosclerosis in the study of Rauramaa et al., but it was variants when compared with IL6 -174 G / C whose associated with a higher cardiovascular mortality in aortic importance has been demonstrated in vitro [5, 22] . Howaneurysm patients in the study of Jones et al.
ever, in view of the current results, further investigations would be free of confounding. Our study thus also 
